{
    "2020-03-19": [
        [
            {
                "time": "",
                "original_text": "静丙2月批签发量增5倍 下游血制品存在涨价可能",
                "features": {
                    "keywords": [
                        "静丙",
                        "批签发量",
                        "增长",
                        "血制品",
                        "涨价"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【山证医药】2月血制品批签发数据跟踪：2月整体批签发高速增长，静丙明显提升",
                "features": {
                    "keywords": [
                        "山证医药",
                        "血制品",
                        "批签发",
                        "增长",
                        "静丙"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}